Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVp Regulatory News (VP.)

Share Price Information for Vp (VP.)

Share Price is delayed by 15 minutes
Get Live Data
460.00    -44.00 (-8.73%)
Bid:
479.00
Ask:
499.00
Spread: 20.00 (4.175%)
Market Cap: £181.77m
VP. Live PriceLast checked at - London Stock Exchange

Intraday Vp Share Chart

PCA Dealing

9 Jun 2025 15:00

RNS Number : 0549M
Vp PLC
09 June 2025
 

 

Immediate Release 9 June 2025

Vp plc

('the Company')

PCA Dealing

 

The Company has been notified that, on 12 February 2025, Jonathan James Jones, a Person Closely Associated with Sarah (Sally) Jones, Company Secretary of the Company and a Person Discharging Managerial Responsibilities, purchased a total of 684 ordinary shares in the Company at a price of 594.75p per share through an automatic dividend reinvestment process.

Further details of the purchase are included in the notifications below, made in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 JONATHAN JAMES JONES

2

 

Reason for the notification

 

a)

 

Position/status

 

Person Closely Associated with Sarah (Sally) Jones, Company Secretary

 

b)

 

Initial notification /Amendment

 

INITIAL NOTIFICATION

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Vp plc

b)

 

LEI

 

213800TBQKKQR7UXZP80

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Vp ORDINARY SHARES OF 5p

Identification code

b)

 

Nature of the transaction

 

PURCHASE OF SHARES IN THE COMPANY THROUGH AN AUTOMATIC DIVIDEND REINVESTMENT

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

594.75p

684

d)

 

Aggregated information

- Aggregated volume

684

- Price

£4,068.09

e)

 

Date of the transaction

 

12 FEBRUARY 2025

f)

 

Place of the transaction

 

LONDON STOCK EXCHANGE

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDZGGVFLDGKZM
Date   Source Headline
3rd Jul 20244:59 pmRNSDirector/PDMR Shareholding
25th Jun 20245:03 pmRNSAnnual Report and Notice of Annual General Meeting
5th Jun 20247:00 amRNSFinal Results
4th Jun 20247:00 amRNSPresentation via Investor Meet Company
23rd May 20247:00 amRNSInvestor Presentation with Equity Development
20th May 20247:00 amRNSNotice of Final Results
16th Apr 20247:00 amRNSTrading Update
5th Feb 20243:26 pmRNSNotification of Major Holdings
28th Nov 20237:00 amRNSInterim Results
23rd Nov 20237:00 amRNSInvestor Presentation with Equity Development
22nd Nov 20237:00 amRNSPresentation via Investor Meet Company
2nd Nov 20237:00 amRNSBoard Appointment
11th Oct 20237:00 amRNSTrading Update & Notice of Interim Results
11th Aug 20237:00 amRNSBoard Changes
25th Jul 20232:57 pmRNSDirector/PDMR Shareholding
20th Jul 20231:11 pmRNSResult of Annual General Meeting
20th Jul 20237:00 amRNSAGM Statement
9th Jun 20233:44 pmRNSDirector/PDMR Shareholding
7th Jun 20237:00 amRNSFinal Results
26th May 20237:00 amRNSInvestor Presentation with Equity Development
25th May 20237:00 amRNSPresentation via Investor Meet Company
24th May 20237:00 amRNSNotice of Final Results
13th Apr 20237:00 amRNSTrading Update
8th Dec 20224:40 pmRNSSecond Price Monitoring Extn
8th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
29th Nov 20227:01 amRNSBoard Changes
29th Nov 20227:00 amRNSInterim Results
18th Nov 20227:00 amRNSPresentation via Equity Development
16th Nov 20227:00 amRNSPresentation via Investor Meet Company
10th Nov 20224:36 pmRNSPrice Monitoring Extension
11th Oct 20227:00 amRNSTrading Update and Notice of Interim Results
7th Oct 20221:32 pmRNSDirector/PDMR Shareholding
7th Oct 202211:31 amRNSHolding(s) in Company
23rd Aug 20224:59 pmRNSDirector/PDMR Shareholding
23rd Aug 20224:59 pmRNSDirector/PDMR Shareholding
23rd Aug 20224:50 pmRNSDirector/PDMR Shareholding
22nd Aug 202211:12 amRNSForm 8.5 (EPT/RI)
19th Aug 202211:20 amRNSForm 8.5 (EPT/RI)
18th Aug 202211:53 amRNSForm 8.5 (EPT/RI)
17th Aug 20229:28 amRNSForm 8.5 (EPT/RI)
16th Aug 20229:57 amRNSForm 8.5 (EPT/RI)
15th Aug 20226:28 pmRNSConclusion of Formal Sale Process
15th Aug 202210:21 amRNSForm 8.5 (EPT/RI)
12th Aug 202210:03 amRNSForm 8.5 (EPT/RI)
11th Aug 202210:02 amRNSForm 8.5 (EPT/RI)
10th Aug 20222:58 pmRNSForm 8.3 - VP plc
10th Aug 202211:52 amRNSForm 8.3 - Vp plc
10th Aug 202211:50 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.